GE HealthCare’s 16.8 Forward P/E and 3.68 P/B Compare Favorably to Stryker
GE HealthCare Technologies holds a Zacks Rank of #2 and a Value grade of B, with a forward P/E of 16.81, PEG of 1.85 and P/B of 3.68, versus Stryker’s Rank #3, PEG 2.26 and P/B 6.59. GE HealthCare’s stronger earnings revisions and lower valuation metrics suggest superior value.
1. Valuation Metrics Comparison
GE HealthCare Technologies reports a forward P/E of 16.81, PEG of 1.85 and P/B of 3.68, while Stryker carries a forward P/E of 25.88, PEG of 2.26 and P/B of 6.59. These metrics underpin GE HealthCare’s Value grade of B compared to Stryker’s C rating.
2. Earnings Revision Trends and Rankings
GE HealthCare’s Zacks Rank of #2 reflects a stronger trend of positive earnings estimate revisions, in contrast with Stryker’s Rank of #3, signaling more favorable analyst outlook changes for GE HealthCare.
3. Investment Implications
The combination of lower valuation ratios and improved earnings outlook positions GE HealthCare as a more attractive value pick for investors targeting the Medical-Products sector.